TonsillectomyNCT05270109
Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity
A study testing BiZact and Cold Steel in people with Tonsillectomy, run by Line Schiøtt Nissen at 1 site in Denmark.
Trial summary
Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Read more about this study
- Who is it for?
- Ages 4 to 100 years
- Conditions the study is for
- Tonsillectomy
- What is being tested?
- BiZact and Cold Steel
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,250 participants
- Where
- 1 siteDenmark
- Study dates
- 1 May 2022to 21 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 100 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Obstruction/ tonsillar hypertrophy.
- Recurrent tonsillitis, including previous peritonsillar abscess
- Chronic tonsillitis
- Systemic complications to tonsillitis (glomerulonephritis)
- Other (Mononucleosis), PFAPA (Periodic Fever, Aphtous stomatitis, pharyngitis, cervical adenitis)
- Foetor ex ore (tonsillar plugs)
- Peritonsillar abscess (Tonsillectomy a chaud)
- Ability to understand the written patient information and to give informed consent
Who cannot join
- Diseases in the hematopoietic system
- Antithrombotic or anticoagulant drugs in the recovery period
- Suspicion of/known tonsillar malignancies or other malignancy
- Patients or caregivers unable to read or speak Danish
- Patients or caregivers unable to use online application for self-evaluation
Trial locations and contacts
1 site in 1 country.
About this study
Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Although, tonsillectomy on benign indication is considered to be a minor and frequently performed surgical procedure, the operation is associated with significant morbidity. Postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent, and PTH is potentially life threatening. In cold steel tonsillectomy, the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. This method has been used for the past 50 years, and is considered the "Gold Standard". However, new so-called "hot techniques have been developed. One of these is an impedance-dependent tissue sealer device (BiZactTM). The equipment used for BiZactTM tonsillectomy is EC certificated (CE nr. 00500). The equipment is commonly used for tonsillectomy both internationally and in Denmark, and preliminary results in both adults and children are promising. However, when a gold standard technique is replaced by a new technique, it is recommended that the decision is based on evidence obtained in randomized controlled designs, and preferably as a multicenter study.
Within the scope of the CE marking of the equipment, the purpose of the present study is to conduct a randomized controlled trial (RCT) in order to investigate whether tonsillectomy performed with BiZactTM "hot" technique is beneficial or at least non-inferior compared to the gold standard cold steel technique in terms of affecting the incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.
Read the detailed description
Tonsillectomy, with or without adenoidectomy, conducted in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number of tonsillectomies has increased over the recent decades. In Denmark, approximately 8.000 tonsillectomies are performed annually. The main indications for surgery are recurrent episodes of acute tonsillitis or upper airway obstruction due to adenotonsillar hypertrophy.
Although commonly performed, tonsillectomy is associated with significant morbidity of which postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent. PTH is a major and potentially life-threatening complication of tonsil surgery. Postoperative pain lasts for approximately two weeks, and may in severe cases result in delayed discharge, a visit at the emergency department or readmission for pain control, re-hydration, and treatment of possible underlaying infection. The incidences of PTH vary between 0.3 and more than 10%. This variation may be caused by different definitions of PTH, but also differences in populations and indications. Cold steel tonsillectomy is considered to be the gold standard surgical technique, but several hot techniques including bipolar techniques, diathermy, and coblation have been developed and used for tonsillectomy. Until now these hot instruments have not proven better than the gold standard technique in reducing PTH, and it is recommended, that these hot techniques should be used with caution. Recently, a new Impedance-dependent tissue sealer device (BiZactTM) has been manufactured and approved for tonsil operations (19). Preliminary results are promising in terms of a PTH rate of 4.5%, a shortened operative time in the hands of both experienced and training surgeons with a median time of 5.1 minutes (range 1.5-26.5 minutes), and a reduced intraoperative blood loss between 1-10 milliliters.
Ideally, when a gold standard technique is replaced by a new technique, it is recommended that the decision should be based on evidence provided by RCTs involving several centers.
The aim of the present is to conduct a RCT to investigate whether tonsillectomy performed with a new hot technique (BiZactTM) is beneficial or at least non-inferior to the gold standard cold steel technique in terms of incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.
The study design is a double blind, multi-centre randomised controlled trial (RCT).
Patients, assessors, and investigators will be blinded to randomisation outcome.
Patients will be recruited at five Dept. Otorhinolaryngology: Region Hospital West, Holstebro, DK, Southwest Regional Hospital, Esbjerg, DK, Lillebaelt Regional Hospital, Vejle, DK, Southern Regional Hospital, Soenderborg, DK, and Aalborg University Hospital, Aalborg, DK.
A total of 1250 eligible patients referred to tonsillectomy on benign indication, who fulfil inclusion criteria and have signed declaration of consent, will be enrolled and randomised in the study; 625 patients are randomized to surgery performed by steel devices (Cold steel group), and 625 patients to surgery by an electrosurgical device (BiZactTM) (Hot group)
In the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. In the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.
An Inter-Rim analysis will be conducted after 650 included patients have fulfilled the study protocol.
In order to strengthen study homogeneity, a pilot-study will initially be carried out with the first ten patients at each of the involved otorhinolaryngology departments.
Randomization is computer generated. Random sequences of 5000 numbers with equal numbers of group assignments will be obtained and concealed at the Tonsil database website (www.tonsil.dk).
Randomisation will be performed automatically by ticking a box on a page of the Tonsil database website.
At the preoperative consultation or at the emergency department, a doctor not involved in the study, will establish registration of the patient in the database and carry out the randomisation.
After the randomisation procedure has been carried out, the outcome will be registered on a hidden page of the Tonsil database website, and it will not be possible to change the outcome. The randomization outcome will only be visible on the web-page from the day of surgery to the day after surgery. Hereafter, it will not be possible to see the randomisation outcome. The operating surgeon will not be able to influence the randomisation outcome.
The investigators hypothesise, that tonsillectomy performed with a bipolar electrosurgical device (BiZactTM) is noninferior to tonsillectomy performed with cold steel technique in terms of affecting postoperative morbidity defined as PTH demanding reoperation with haemostasis and pain.
The present study will elucidate whether tonsillectomy performed with a bipolar electrosurgical instrument BiZactTM induces alleged beneficial effects or at least is noninferior to tonsillectomy performed with cold steel instruments. Moreover, should the study uncover that tonsillectomy performed with a bipolar electrosurgical instrument BiZactTM can reduce postoperative morbidity, frequency of reoperations, as well as surgical time, it may potentially optimise future treatment for patients and reduce socio-economic costs. Thus, the present RCT will be followed with an alongside economic evaluation.
- Conditions
- Tonsillectomy
- Being tested
- BiZact, Cold Steel
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BiZactProcedure or surgery
In the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.
Cold SteelProcedure or surgery
In the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery.
| Study group | Role | What they receive |
|---|---|---|
| BiZact | Experimental | Not described Receives: Procedure: BiZact |
| Cold Steel | Active comparator | Not described Receives: Procedure: Cold Steel |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of PTH
- Incidence of PTH defined as haemorrhage requiring haemostasis with; bipolar electric coagulation, ligature, compression and/or medical treatment with antifibrinolyticum within the first 24 hours after surgery until 30 days after surgery.
Measured: 24 hours until 30 days after surgery
Postoperative pain
- Postoperative pain assessed on a 11point numeric rating scale ranging from 0 "no pain" to 10 "worst possible pain". The Wong-Baker Faces rating scale is used for children.
Measured: From the day of surgery until 14 days after the surgery
Secondary outcomes (6)
Blood loss
- Intraoperative blood loss assessed by standardized blood weighing. The weight in grams will be converted to milliliters.
Measured: Intraoperative
Knife time
- Operative time in minutes from the Boyle-Davis gag is placed until it is removed.
Measured: First day of surgery
PROM
- patient reported outcome measures (PROM) of postoperative recovery (days until return to normal diet, days until return to physical activity, and days until return to work, school- or child care).
Measured: From the day of the surgery until 6 months after the surgery
Unscheduled contacts to the health care system
- Number of unscheduled contacts to the health care system.
Measured: From the day of the surgery until 14 days after
Health related quality of life
- Health related quality of life using EQ5D
Measured: From the day of the surgery until 6 months after the surgery
Smell and taste
Smell and taste validated questionnaire
Measured: From the day of the surgery until 6 months after the surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2022
- Study start1 May 2022
- Primary completion25 Jul 2024
- Study completion21 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for TonsillectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 1,250 participants (actual)
Sponsor and investigators
- Lead sponsor
- Line Schiøtt Nissen
- Sponsor type
- University, hospital or other
- Collaborators
- Sygehus Lillebaelt, Sonderborg Hospital, Esbjerg Hospital - University Hospital of Southern Denmark, Aalborg University Hospital
- Responsible party
- Sponsor-investigator, Line Schiøtt Nissen, Regional Hospital West Jutland
- Investigators
- Line S Nissen, MD, Principal investigator, Regional Hospital West Jutland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05270109
- Sponsor's protocol ID
- 2202151
- Status last verified
- Feb 2025
- First submitted
- 15 Feb 2022
- Last updated
- 17 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Molhave M, Lyhne NM, Jensen DF, Nielsen SH, Hahn P, Holm JK, Ovesen T, Bertelsen J. BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial. Eur Arch Otorhinolaryngol. 2025 Dec;282(12):6449-6457. doi: 10.1007/s00405-025-09703-3. Epub 2025 Oct 13.
PubMed 41083818Nissen LS, Bertelsen J, Lyhne NM, Nielsen SH, Hahn P, Holm J, Ovesen T. Cold steel versus impedance-dependent tissue sealer tonsillectomy - a study protocol for a randomised controlled trial. Dan Med J. 2023 Nov 23;70(12):A06230366.
PubMed 38018707
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity
- ClinicalTrials.gov ID
- NCT05270109
- Acronym / sponsor ID
- 2202151
- Conditions
- Tonsillectomy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,250 participants (actual)
- Lead sponsor
- Line Schiøtt NissenUniversity, hospital or other
- Collaborators
- Sygehus Lillebaelt, Sonderborg Hospital, Esbjerg Hospital - University Hospital of Southern Denmark, Aalborg University Hospital
- Study start
- 1 May 2022 (actual)
- Primary completion
- 25 Jul 2024 (actual)
- Study completion
- 21 Jan 2025 (actual)
- First posted
- 8 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Although, tonsillectomy on benign indication is considered to be a minor and frequently performed surgical procedure, the operation is associated with significant morbidity. Postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent, and PTH is potentially life threatening. In cold steel tonsillectomy, the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. This method has been used for the past 50 years, and is considered the "Gold Standard". However, new so-called "hot techniques have been developed. One of these is an impedance-dependent tissue sealer device (BiZactTM). The equipment used for BiZactTM tonsillectomy is EC certificated (CE nr. 00500). The equipment is commonly used for tonsillectomy both internationally and in Denmark, and preliminary results in both adults and children are promising. However, when a gold standard technique is replaced by a new technique, it is recommended that the decision is based on evidence obtained in randomized controlled designs, and preferably as a multicenter study.
Within the scope of the CE marking of the equipment, the purpose of the present study is to conduct a randomized controlled trial (RCT) in order to investigate whether tonsillectomy performed with BiZactTM "hot" technique is beneficial or at least non-inferior compared to the gold standard cold steel technique in terms of affecting the incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.
Detailed description
Tonsillectomy, with or without adenoidectomy, conducted in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number of tonsillectomies has increased over the recent decades. In Denmark, approximately 8.000 tonsillectomies are performed annually. The main indications for surgery are recurrent episodes of acute tonsillitis or upper airway obstruction due to adenotonsillar hypertrophy.
Although commonly performed, tonsillectomy is associated with significant morbidity of which postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent. PTH is a major and potentially life-threatening complication of tonsil surgery. Postoperative pain lasts for approximately two weeks, and may in severe cases result in delayed discharge, a visit at the emergency department or readmission for pain control, re-hydration, and treatment of possible underlaying infection. The incidences of PTH vary between 0.3 and more than 10%. This variation may be caused by different definitions of PTH, but also differences in populations and indications. Cold steel tonsillectomy is considered to be the gold standard surgical technique, but several hot techniques including bipolar techniques, diathermy, and coblation have been developed and used for tonsillectomy. Until now these hot instruments have not proven better than the gold standard technique in reducing PTH, and it is recommended, that these hot techniques should be used with caution. Recently, a new Impedance-dependent tissue sealer device (BiZactTM) has been manufactured and approved for tonsil operations (19). Preliminary results are promising in terms of a PTH rate of 4.5%, a shortened operative time in the hands of both experienced and training surgeons with a median time of 5.1 minutes (range 1.5-26.5 minutes), and a reduced intraoperative blood loss between 1-10 milliliters.
Ideally, when a gold standard technique is replaced by a new technique, it is recommended that the decision should be based on evidence provided by RCTs involving several centers.
The aim of the present is to conduct a RCT to investigate whether tonsillectomy performed with a new hot technique (BiZactTM) is beneficial or at least non-inferior to the gold standard cold steel technique in terms of incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.
The study design is a double blind, multi-centre randomised controlled trial (RCT).
Patients, assessors, and investigators will be blinded to randomisation outcome.
Patients will be recruited at five Dept. Otorhinolaryngology: Region Hospital West, Holstebro, DK, Southwest Regional Hospital, Esbjerg, DK, Lillebaelt Regional Hospital, Vejle, DK, Southern Regional Hospital, Soenderborg, DK, and Aalborg University Hospital, Aalborg, DK.
A total of 1250 eligible patients referred to tonsillectomy on benign indication, who fulfil inclusion criteria and have signed declaration of consent, will be enrolled and randomised in the study; 625 patients are randomized to surgery performed by steel devices (Cold steel group), and 625 patients to surgery by an electrosurgical device (BiZactTM) (Hot group)
In the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. In the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.
An Inter-Rim analysis will be conducted after 650 included patients have fulfilled the study protocol.
In order to strengthen study homogeneity, a pilot-study will initially be carried out with the first ten patients at each of the involved otorhinolaryngology departments.
Randomization is computer generated. Random sequences of 5000 numbers with equal numbers of group assignments will be obtained and concealed at the Tonsil database website (www.tonsil.dk).
Randomisation will be performed automatically by ticking a box on a page of the Tonsil database website.
At the preoperative consultation or at the emergency department, a doctor not involved in the study, will establish registration of the patient in the database and carry out the randomisation.
After the randomisation procedure has been carried out, the outcome will be registered on a hidden page of the Tonsil database website, and it will not be possible to change the outcome. The randomization outcome will only be visible on the web-page from the day of surgery to the day after surgery. Hereafter, it will not be possible to see the randomisation outcome. The operating surgeon will not be able to influence the randomisation outcome.
The investigators hypothesise, that tonsillectomy performed with a bipolar electrosurgical device (BiZactTM) is noninferior to tonsillectomy performed with cold steel technique in terms of affecting postoperative morbidity defined as PTH demanding reoperation with haemostasis and pain.
The present study will elucidate whether tonsillectomy performed with a bipolar electrosurgical instrument BiZactTM induces alleged beneficial effects or at least is noninferior to tonsillectomy performed with cold steel instruments. Moreover, should the study uncover that tonsillectomy performed with a bipolar electrosurgical instrument BiZactTM can reduce postoperative morbidity, frequency of reoperations, as well as surgical time, it may potentially optimise future treatment for patients and reduce socio-economic costs. Thus, the present RCT will be followed with an alongside economic evaluation.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| BiZact | Experimental | Procedure: BiZact |
| Cold Steel | Active comparator | Procedure: Cold Steel |
Who may qualify
- Ages
- 4 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (8 listed)
- Obstruction/ tonsillar hypertrophy.
- Recurrent tonsillitis, including previous peritonsillar abscess
- Chronic tonsillitis
- Systemic complications to tonsillitis (glomerulonephritis)
- Other (Mononucleosis), PFAPA (Periodic Fever, Aphtous stomatitis, pharyngitis, cervical adenitis)
Key exclusion criteria (5 listed)
- Diseases in the hematopoietic system
- Antithrombotic or anticoagulant drugs in the recovery period
- Suspicion of/known tonsillar malignancies or other malignancy
- Patients or caregivers unable to read or speak Danish
- Patients or caregivers unable to use online application for self-evaluation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BiZactIn the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue. | Procedure or surgery | BiZact |
| Cold SteelIn the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. | Procedure or surgery | Cold Steel |
Primary outcome
Incidence of PTH
Time frame: 24 hours until 30 days after surgery
• Incidence of PTH defined as haemorrhage requiring haemostasis with; bipolar electric coagulation, ligature, compression and/or medical treatment with antifibrinolyticum within the first 24 hours after surgery until 30 days after surgery.
Postoperative pain
Time frame: From the day of surgery until 14 days after the surgery
• Postoperative pain assessed on a 11point numeric rating scale ranging from 0 "no pain" to 10 "worst possible pain". The Wong-Baker Faces rating scale is used for children.
6 secondary outcomes
Blood loss
Time frame: Intraoperative
Knife time
Time frame: First day of surgery
PROM
Time frame: From the day of the surgery until 6 months after the surgery
Unscheduled contacts to the health care system
Time frame: From the day of the surgery until 14 days after
Health related quality of life
Time frame: From the day of the surgery until 6 months after the surgery
Smell and taste
Time frame: From the day of the surgery until 6 months after the surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2025.
- Derived from this study: PubMed 41083818Molhave M, Lyhne NM, Jensen DF, Nielsen SH, Hahn P, Holm JK, Ovesen T, Bertelsen J. BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial. Eur Arch Otorhinolaryngol. 2025 Dec;282(12):6449-6457. doi: 10.1007/s00405-025-09703-3. Epub 2025 Oct 13.
- Derived from this study: PubMed 38018707Nissen LS, Bertelsen J, Lyhne NM, Nielsen SH, Hahn P, Holm J, Ovesen T. Cold steel versus impedance-dependent tissue sealer tonsillectomy - a study protocol for a randomised controlled trial. Dan Med J. 2023 Nov 23;70(12):A06230366.
- Individual participant dataSharing planned: No
Related trials for Tonsillectomy
Not yet recruitingObservational study
Comparison of IV Dexmedetomidine Versus Clonidine Versus no Alpha 2 Agonist on Emergency Delirium, PACU Length of Stay and Time to Hospital Discharge in Children Undergoing (Adeno)Tonsillectomy: a Prospective Observational Study
Emergency Delirium, Postoperative Delirium (POD)
Not yet recruiting
Boyle-Davis Mouth Gag Timing in Pediatric Tonsil Surgery
Tonsillectomy and Adenotonsillectomy in Children
Recruiting
Coblator Wand Comparative Analysis
Tonsillectomy, Adenoidectomy
Not yet recruitingPhase 4
Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management
Tonsillectomy, Pharyngoplasty
Not yet recruitingPhase 3
Postoperative Care After Tonsillectomy
Tonsillectomy, Bleeding
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Line S Nissen, MD principal investigator
Regional Hospital West Jutland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BiZact and Cold Steel in people with Tonsillectomy, run by Line Schiøtt Nissen at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of PTH (time frame: 24 hours until 30 days after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05270109, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2025; AzTrials last refreshed its copy on 6 Nov 2026.